Evidence map›Paper›PMID 41097308›Full record

ArticleMolecules (Basel, Switzerland)2025

Evaluation of Biocompatible and Biodegradable PES/PCL Membranes for Potential Use in Biomedical Devices: From Fouling Resistance to Environmental Safety.

Cezary Wojciechowski, Monika Wasyłeczko, Dorota Lewińska, Andrzej Chwojnowski

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cezary WojciechowskiNałęcz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Science, 02-109 Warsaw, Poland.
Monika WasyłeczkoNałęcz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Science, 02-109 Warsaw, Poland.ORCID 0000-0002-8925-292X
Dorota LewińskaNałęcz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Science, 02-109 Warsaw, Poland.ORCID 0000-0002-9978-9157
Andrzej ChwojnowskiNałęcz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Science, 02-109 Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The paper presents a method for obtaining partially degradable capillary membranes from a polyethersulfone/polycaprolactone (PES/PCL) mixture. PES/PCL membranes were obtained by the phase inversion technique with dry/wet spinning and then subjected to controlled degradation in an alkaline environment (1 M NaOH) and simulated body fluid (SBF with pH 7.4) using the flow method. The aim of the work was to select and apply a degradable, non-toxic, simple polymer as a removable component of the membrane structure. The degradable component of the membranes was PCL, the gradual hydrolysis of which was aimed at increasing the porosity and improving the transport properties of the membranes during operation. The membrane properties, such as hydraulic permeability coefficient (UFC), retention coefficient, and structural morphology, were assessed using scanning electron microscopy (SEM) before and after degradation. Analysis of SEM images performed with MeMoExplorer

Indexed as

Biocompatible MaterialsBiofoulingMembranes, ArtificialPolyestersPolymersSulfonesHydrolysisMicroscopy, Electron, ScanningPermeabilityPorosityBiocompatible MaterialsMembranes, ArtificialpolycaprolactonePolyesterspolyether sulfonePolymersSulfonesbiocompatibilitybiomaterialscapillary membranesdegradationfoulinghydrolysismedical devicespolymer-based materialsretentionsynthetic polymers

Identifiers

PMID41097308
PMCPMC12526486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.